Amran600 Posted - 5 days ago

$PHG Philips’ innovations in healthcare technology and consumer devices position it as a leader in its field.

LewisDaKat Posted - 3 weeks ago

$PHG News Philips optimizes CT workflows with in-house AI, launches CT 5300 in North America at #RSNA2024 https://marketwirenews.com/news-releases/philips-optimizes-ct-workflows-with-in-house-ai-laun-8422856450251575.html $PHG

LewisDaKat Posted - 3 weeks ago

News Article $PHG Better care for more people: Philips innovates in AI-enabled imaging and cloud-based informatics at #RSNA24 https://marketwirenews.com/news-releases/better-care-for-more-people-philips-innovates-in-ai--5286902896839872.html $PHG

DonCorleone77 Posted - 1 month ago

$PHG $AMZN Philips expands strategic collaboration with Amazon Web Services Philips (PHG) announced the expansion of its strategic collaboration with Amazon (AMZN) Web Services, or AWS, to offer Philips' integrated diagnostics portfolio in the cloud, including radiology, digital pathology, cardiology and AI advanced visualization solutions. The collaboration aims to unify diagnostic workflows, improving access to insights and driving better outcomes across clinical specialties. Philips has already transitioned over 150 sites across North America and Latin America to Philips HealthSuite Imaging on AWS and is building on its collaboration with AWS to accelerate the migration of health systems to the cloud, and will expand to include customer cloud migrations in Europe.

TheTradeXchange Posted - 1 month ago

$PHG - Philips and icometrix advance precision diagnosis in neurology with innovative AI-based imaging solutions at #RSNA24

TheTradeXchange Posted - 1 month ago

$PHG - Philips advances remote imaging leadership with FDA 510(k) clearance for innovative remote scanning and protocol management capabilities

DonCorleone77 Posted - 1 month ago

$PHG Philips removed from European Conviction List at Goldman Sachs Goldman Sachs analysts removed Philips from the firm's European Conviction List as part of its monthly update.

cdsnuts93 Posted - 10/31/24

@Icemanja Back to the conversation of Suitors. I think Royal Phillips $PHG could be a match. They just rolled out a stent that helps a different issue in the CVI realm. https://www.philips.com/a-w/about/news/archive/standard/news/press/2024/philips-launches-duo-venous-stent-system-for-treatment-of-symptomatic-venous-outflow-obstruction.html#

cubie Posted - 10/29/24

@EBE_Day @indievestments @judgeyoung2 @Alvi722 @jenbunn @Ollip @ribbey @TraderRapp @tonyctl @lukenight I missed this post too ebe 🙈😅, did $phg work this morning?

Himel92 Posted - 10/29/24

The Last month Performance for $PHG Opening Price: $32.76 Closing Price: $26.62 Highest Price: $32.91 Lowest Price: $26.09 Percentage Change: -18.74% Data provider: AITX

briefingcom Posted - 10/29/24

$PHG: Philips to further roll out RATE: AI for Early Infection Detection at U.S. Department of defense through four-year, $25 million contract. Over the next four years, the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense, will invest $25 million to make the technology more accessible in the field.

codefocus Posted - 10/29/24

$BYND and $OTLY earnings next week 💰 $DOGE.X and $BBKCF woke up!! 💰 Glad I sold $PHG before the drop, though will jump in again later.

briefingcom Posted - 10/29/24

$PHG: Philips (+2%) upgraded to Hold from Underperform at Jefferies https://www.briefing.com/calendars/updown?Filter=Upgrades

upgrayeddd Posted - 10/28/24

$PHG It's wild how so many traders are obsessed with China.

Stilzittenenbijkopen Posted - 10/28/24

$PHG loading more! Easy rebound🚀

GambitMentality Posted - 10/28/24

Today’s #StockMarket EOD Biggest Losers by %, led by $DOGZ $TMTC and $PHG to lead the TOP 3

TheDayTradingAcademy Posted - 10/28/24

Philips $PHG said on Monday that demand in China slumped significantly in recent months, forcing the Dutch medical devices maker to lower its sales outlook for the year & sending its European shares down -16% at €24.61 ($26.61), in their biggest 1 day loss in 26 years. The company said it had been hit by a deterioration of consumer confidence in China & by an ongoing state-led anti-corruption campaign there which dragged down orders from Chinese hospitals. The stock is down -9.56% in the past 3 months, but up +20.71% in 2024 & +44.92% y/y, with a market cap of €27.5B ($29.74B).

stockleapp Posted - 10/28/24

$PHG Philips gets hammered after Q3 earnings: EPS: €0.32 (Est. €0.35) Revenue: €4.4B (Est. €4.54B) “In the quarter, demand from hospitals and consumers in China further deteriorated", "We have adjusted our full-year sales outlook to reflect the continued impact from China" - Roy Jakobs, CEO

Jamesiam Posted - 10/28/24

$PHG this was $19 a few months ago

swingingtech Posted - 10/28/24

$PHG https://wallstreetwaves.com/philips-stock-a-deep-dive-into-oversold-conditions-phg/

briefingcom Posted - 10/28/24

$PHG: A surprising turn of events in China during Q3 battered Philips (-16.3%), spurring a sharp reduction in its FY24 comparable sales growth outlook. Last quarter, the medical and personal health device maker was optimistic that business in China, which comprises around 10% of revenue, had stabilized, adding that the region should gradually contribute to positive order growth over the coming quarters. Given this context, investors are stunned by the fact that not only did China fail to add to order growth in the quarter, but that conditions deteriorated, driving today's significant sell-off. PHG missed earnings estimates in Q3 by a few pennies, a common occurrence for the company, making this development not overly surprising. https://www.briefing.com/story-stocks/archive/2024/10/28/philips-encounters-deteriorating-conditions-in-china-in-q3-clips-fy24-guidance-(phg)?utm_campaign=storystocks&utm_medium=social&utm_source=st&utm_content=link

MoonInvestmentsss Posted - 10/28/24

$PHG $27.74 minimum.

MoonInvestmentsss Posted - 10/28/24

$LUNR $AMZN $INTC $PHG $IBRX This is how money is made. Riding the bullish waves!🚀

MoonInvestmentsss Posted - 10/28/24

$LUNR $INTC $PHG $IBRX BUYs.

cubie Posted - 10/28/24

@EBE_Day @indievestments @Alvi722 @judgeyoung2 @jenbunn @Ollip @ribbey @TraderRapp @tonyctl @lukenight $phg sure wasn't ebe. u didnt mention it till after close? 😬🙄.

ribbey Posted - 10/28/24

@cubie @lukenight @indievestments @Alvi722 @judgeyoung2 @jenbunn @Ollip @EBE_Day @TraderRapp @tonyctl $PHG er 👀

wallstengine Posted - 10/28/24

$PHG | Philips Q3 FY24 Earnings Highlights 🔹 Adjusted EPS: €0.32 (Est. €0.35) 🔴 🔹 Adj EBITA: €516M (Est. €535.1M) 🔴; Margin 11.8% 🔹 Sales: €4.38B (Est. €4.58B) 🔴; Flat Comp Sales Growth CUTS FY24 Guidance: 🔹 Comparable Sales Growth: 0.5%-1.5% (Prev. 3%-5%) 🔴 🔹 Free Cash Flow: ~€900M (Prev. €900M-€1.1B) 😕 🔹 Adjusted EBITA Margin: ~11.5% Business Performance & Outlook: 🔹 Order Intake: DOWN -2%, impacted by weak China demand 🔹 China: Significant deterioration in demand led to revised sales outlook 🔹 Non-China Markets: Steady growth of 3%-5%

DonCorleone77 Posted - 10/28/24

$PHG Philips sees FY24 adjusted EDITDA margin 11.5% The company said, "The significant deterioration in China demand leads to an updated comparable sales growth outlook range of 0.5-1.5% for the full year 2024. Comparable sales growth outside of China remains within the 3-5% range. Adjusted EBITA margin is expected to be around 11.5%, the upper end of the range, with free cashflow at around EUR 0.9 billion, at the lower end of the range. Within an ongoing challenging macro environment, Philips remains focused on successfully executing its three-year plan to drive operational improvement and create value with sustainable impact. The uncertainties signaled in earlier quarters have intensified in China and are expected to continue. The outlook excludes the potential impact of the ongoing Philips Respironics-related legal proceedings, including the investigation by the US Department of Justice."

DonCorleone77 Posted - 10/28/24

$PHG Philips reports Q3 EPS 32 vs. 32c last year Reports Q3 revenue EUR 4.38B vs. EUR 4.47B. Group comparable sales were flat. Comparable order intake in the quarter declined 2%. The company said, ""In the quarter, demand from hospitals and consumers in China further deteriorated, while we continue to see solid growth in other regions. We have adjusted our full-year sales outlook to reflect the continued impact from China. Strong improvement in profitability was driven by progress on our execution priorities, productivity measures and the improved margins of our AI-driven, industry-leading innovations. Within a challenging macro environment, we remain focused on successfully executing our three-year plan to fully capture growth and margin expansion opportunities. With patient safety as our number one priority, we are committed to delivering better care for more people."

Okadarlan Posted - 10/28/24

$PHG still freerolling and nice sale.